ID   FPPS_HUMAN              Reviewed;         419 AA.
AC   P14324; D3DV91; E9PCI9; Q96G29;
DT   01-JAN-1990, integrated into UniProtKB/Swiss-Prot.
DT   25-NOV-2008, sequence version 4.
DT   10-MAY-2017, entry version 195.
DE   RecName: Full=Farnesyl pyrophosphate synthase;
DE            Short=FPP synthase;
DE            Short=FPS;
DE            EC=2.5.1.10;
DE   AltName: Full=(2E,6E)-farnesyl diphosphate synthase;
DE   AltName: Full=Dimethylallyltranstransferase;
DE            EC=2.5.1.1;
DE   AltName: Full=Farnesyl diphosphate synthase;
DE   AltName: Full=Geranyltranstransferase;
GN   Name=FDPS; Synonyms=FPS, KIAA1293;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=1968462;
RA   Wilkin D.J., Kutsunai S.Y., Edwards P.A.;
RT   "Isolation and sequence of the human farnesyl pyrophosphate synthetase
RT   cDNA. Coordinate regulation of the mRNAs for farnesyl pyrophosphate
RT   synthetase, 3-hydroxy-3-methylglutaryl coenzyme A reductase, and 3-
RT   hydroxy-3-methylglutaryl coenzyme A synthase by phorbol ester.";
RL   J. Biol. Chem. 265:4607-4614(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Bone marrow;
RX   PubMed=7584026; DOI=10.1093/dnares/1.1.27;
RA   Nomura N., Miyajima N., Sazuka T., Tanaka A., Kawarabayasi Y.,
RA   Sato S., Nagase T., Seki N., Ishikawa K., Tabata S.;
RT   "Prediction of the coding sequences of unidentified human genes. I.
RT   The coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by
RT   analysis of randomly sampled cDNA clones from human immature myeloid
RT   cell line KG-1.";
RL   DNA Res. 1:27-35(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-312 (ISOFORM 2).
RG   The MGC Project Team;
RL   Submitted (APR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 74-419.
RC   TISSUE=Liver;
RX   PubMed=2690933; DOI=10.1021/bi00446a025;
RA   Sheares B.T., White S.S., Molowa D.T., Chan K., Ding V.D.-H.,
RA   Kroon P.A., Bostedor R.G., Karkas J.D.;
RT   "Cloning, analysis, and bacterial expression of human farnesyl
RT   pyrophosphate synthetase and its regulation in Hep G2 cells.";
RL   Biochemistry 28:8129-8135(1989).
RN   [9]
RP   INTERACTION WITH HTLV-1 P13(II).
RX   PubMed=11773414; DOI=10.1128/JVI.76.3.1400-1414.2002;
RA   Lefebvre L., Vanderplasschen A., Ciminale V., Heremans H.,
RA   Dangoisse O., Jauniaux J.-C., Toussaint J.-F., Zelnik V., Burny A.,
RA   Kettmann R., Willems L.;
RT   "Oncoviral bovine leukemia virus G4 and human T-cell leukemia virus
RT   type 1 p13(II) accessory proteins interact with farnesyl pyrophosphate
RT   synthetase.";
RL   J. Virol. 76:1400-1414(2002).
RN   [10]
RP   INTERACTION WITH RSAD2, AND ENZYME REGULATION.
RX   PubMed=18005724; DOI=10.1016/j.chom.2007.06.009;
RA   Wang X., Hinson E.R., Cresswell P.;
RT   "The interferon-inducible protein viperin inhibits influenza virus
RT   release by perturbing lipid rafts.";
RL   Cell Host Microbe 2:96-105(2007).
RN   [11]
RP   REVIEW.
RX   PubMed=15827605;
RA   Szkopinska A., Plochocka D.;
RT   "Farnesyl diphosphate synthase; regulation of product specificity.";
RL   Acta Biochim. Pol. 52:45-55(2005).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1 (ISOFORM 2), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-123 AND LYS-353, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1 (ISOFORM 2), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1 (ISOFORM 2), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [18]
RP   INVOLVEMENT IN POROK9, AND VARIANT POROK9 GLN-179.
RX   PubMed=26202976; DOI=10.7554/eLife.06322;
RA   Zhang Z., Li C., Wu F., Ma R., Luan J., Yang F., Liu W., Wang L.,
RA   Zhang S., Liu Y., Gu J., Hua W., Fan M., Peng H., Meng X., Song N.,
RA   Bi X., Gu C., Zhang Z., Huang Q., Chen L., Xiang L., Xu J., Zheng Z.,
RA   Jiang Z.;
RT   "Genomic variations of the mevalonate pathway in porokeratosis.";
RL   Elife 4:E06322-E06322(2015).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (1.94 ANGSTROMS) OF 72-419, AND SUBUNIT.
RX   PubMed=16892359; DOI=10.1002/cmdc.200500059;
RA   Rondeau J.-M., Bitsch F., Bourgier E., Geiser M., Hemmig R.,
RA   Kroemer M., Lehmann S., Ramage P., Rieffel S., Strauss A., Green J.R.,
RA   Jahnke W.;
RT   "Structural basis for the exceptional in vivo efficacy of
RT   bisphosphonate drugs.";
RL   ChemMedChem 1:267-273(2006).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 67-419 IN COMPLEXES WITH
RP   MAGNESIUM IONS; RISEDRONATE AND ZOLEDRONATE, AND CATALYTIC ACTIVITY.
RX   PubMed=16684881; DOI=10.1073/pnas.0601643103;
RA   Kavanagh K.L., Guo K., Dunford J.E., Wu X., Knapp S., Ebetino F.H.,
RA   Rogers M.J., Russell R.G., Oppermann U.;
RT   "The molecular mechanism of nitrogen-containing bisphosphonates as
RT   antiosteoporosis drugs.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:7829-7834(2006).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 67-419 IN COMPLEXES WITH
RP   MAGNESIUM AND BIPHOSPHONATES.
RX   PubMed=19309137; DOI=10.1021/ja808285e;
RA   Zhang Y., Cao R., Yin F., Hudock M.P., Guo R.-T., Krysiak K.,
RA   Mukherjee S., Gao Y.-G., Robinson H., Song Y., No J.H., Bergan K.,
RA   Leon A., Cass L., Goddard A., Chang T.-K., Lin F.-Y., Van Beek E.,
RA   Papapoulos S., Wang A.H.-J., Kubo T., Ochi M., Mukkamala D.,
RA   Oldfield E.;
RT   "Lipophilic bisphosphonates as dual farnesyl/geranylgeranyl
RT   diphosphate synthase inhibitors: an X-ray and NMR investigation.";
RL   J. Am. Chem. Soc. 131:5153-5162(2009).
CC   -!- FUNCTION: Key enzyme in isoprenoid biosynthesis which catalyzes
CC       the formation of farnesyl diphosphate (FPP), a precursor for
CC       several classes of essential metabolites including sterols,
CC       dolichols, carotenoids, and ubiquinones. FPP also serves as
CC       substrate for protein farnesylation and geranylgeranylation.
CC       Catalyzes the sequential condensation of isopentenyl pyrophosphate
CC       with the allylic pyrophosphates, dimethylallyl pyrophosphate, and
CC       then with the resultant geranylpyrophosphate to the ultimate
CC       product farnesyl pyrophosphate.
CC   -!- CATALYTIC ACTIVITY: Dimethylallyl diphosphate + isopentenyl
CC       diphosphate = diphosphate + geranyl diphosphate.
CC       {ECO:0000269|PubMed:16684881}.
CC   -!- CATALYTIC ACTIVITY: Geranyl diphosphate + isopentenyl diphosphate
CC       = diphosphate + (2E,6E)-farnesyl diphosphate.
CC       {ECO:0000269|PubMed:16684881}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC       Note=Binds 3 Mg(2+) ions per subunit.;
CC   -!- ENZYME REGULATION: Inactivated by interferon-induced RSAD2. This
CC       inactivation may result of disruption of lipid rafts at the plasma
CC       membrane, and thus have an antiviral effect since many enveloped
CC       viruses need lipid rafts to bud efficiently out of the cell.
CC       {ECO:0000269|PubMed:18005724}.
CC   -!- PATHWAY: Isoprenoid biosynthesis; farnesyl diphosphate
CC       biosynthesis; farnesyl diphosphate from geranyl diphosphate and
CC       isopentenyl diphosphate: step 1/1.
CC   -!- PATHWAY: Isoprenoid biosynthesis; geranyl diphosphate
CC       biosynthesis; geranyl diphosphate from dimethylallyl diphosphate
CC       and isopentenyl diphosphate: step 1/1.
CC   -!- SUBUNIT: Homodimer. Interacts with RSAD2. Interacts with HTLV-1
CC       protein p13(II). {ECO:0000269|PubMed:11773414,
CC       ECO:0000269|PubMed:16892359, ECO:0000269|PubMed:18005724}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P14324-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P14324-2; Sequence=VSP_046958;
CC         Note=Contains a N-acetylmethionine at position 1.
CC         {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:22223895,
CC         ECO:0000244|PubMed:22814378};
CC   -!- DISEASE: Porokeratosis 9, multiple types (POROK9) [MIM:616631]: A
CC       form of porokeratosis, a disorder of faulty keratinization
CC       characterized by one or more atrophic patches surrounded by a
CC       distinctive hyperkeratotic ridgelike border called the cornoid
CC       lamella. The keratotic lesions can progress to overt cutaneous
CC       neoplasms, typically squamous cell carcinomas. Multiple clinical
CC       variants of porokeratosis are recognized, including porokeratosis
CC       of Mibelli, linear porokeratosis, disseminated superficial actinic
CC       porokeratosis, palmoplantar porokeratosis, and punctate
CC       porokeratosis. Different clinical presentations can be observed
CC       among members of the same family. Individuals expressing more than
CC       one variant have also been reported.
CC       {ECO:0000269|PubMed:26202976}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the FPP/GGPP synthase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA03523.2; Type=Erroneous initiation; Note=Translation N-terminally shortened.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J05262; AAA52423.1; -; mRNA.
DR   EMBL; D14697; BAA03523.2; ALT_INIT; mRNA.
DR   EMBL; AK291084; BAF83773.1; -; mRNA.
DR   EMBL; AL139410; CAI12715.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW53076.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW53077.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW53078.1; -; Genomic_DNA.
DR   EMBL; BC010004; AAH10004.1; -; mRNA.
DR   EMBL; BQ062616; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; M29863; AAA35820.1; -; mRNA.
DR   CCDS; CCDS1110.1; -. [P14324-1]
DR   CCDS; CCDS44241.1; -. [P14324-2]
DR   PIR; A35726; A35726.
DR   RefSeq; NP_001129293.1; NM_001135821.1. [P14324-1]
DR   RefSeq; NP_001129294.1; NM_001135822.1. [P14324-2]
DR   RefSeq; NP_001229753.1; NM_001242824.1. [P14324-2]
DR   RefSeq; NP_001229754.1; NM_001242825.1.
DR   RefSeq; NP_001995.1; NM_002004.3. [P14324-1]
DR   RefSeq; XP_005245019.1; XM_005244962.1. [P14324-2]
DR   RefSeq; XP_005245020.1; XM_005244963.1. [P14324-2]
DR   UniGene; Hs.335918; -.
DR   PDB; 1YQ7; X-ray; 2.20 A; A=67-419.
DR   PDB; 1YV5; X-ray; 2.00 A; A=67-419.
DR   PDB; 1ZW5; X-ray; 2.30 A; A=67-419.
DR   PDB; 2F7M; X-ray; 2.30 A; F=72-419.
DR   PDB; 2F89; X-ray; 2.60 A; F=72-419.
DR   PDB; 2F8C; X-ray; 2.20 A; F=72-419.
DR   PDB; 2F8Z; X-ray; 2.60 A; F=72-419.
DR   PDB; 2F92; X-ray; 2.15 A; F=72-419.
DR   PDB; 2F94; X-ray; 1.94 A; F=72-419.
DR   PDB; 2F9K; X-ray; 2.06 A; F=72-419.
DR   PDB; 2OPM; X-ray; 2.40 A; A=67-419.
DR   PDB; 2OPN; X-ray; 2.70 A; A=67-419.
DR   PDB; 2QIS; X-ray; 1.80 A; A=67-419.
DR   PDB; 2RAH; X-ray; 2.00 A; A=67-419.
DR   PDB; 2VF6; X-ray; 2.10 A; A=67-419.
DR   PDB; 3B7L; X-ray; 1.95 A; A=67-419.
DR   PDB; 3CP6; X-ray; 1.95 A; A=67-419.
DR   PDB; 3N1V; X-ray; 2.18 A; F=72-419.
DR   PDB; 3N1W; X-ray; 2.56 A; F=72-419.
DR   PDB; 3N3L; X-ray; 2.74 A; F=72-419.
DR   PDB; 3N45; X-ray; 1.88 A; F=72-419.
DR   PDB; 3N46; X-ray; 2.35 A; F=72-419.
DR   PDB; 3N49; X-ray; 2.50 A; F=72-419.
DR   PDB; 3N5H; X-ray; 2.20 A; F=72-419.
DR   PDB; 3N5J; X-ray; 2.35 A; F=72-419.
DR   PDB; 3N6K; X-ray; 2.25 A; F=72-419.
DR   PDB; 3RYE; X-ray; 2.10 A; A=71-419.
DR   PDB; 3S4J; X-ray; 1.95 A; A=71-419.
DR   PDB; 4DEM; X-ray; 1.85 A; F=67-419.
DR   PDB; 4GA3; X-ray; 2.39 A; A=72-419.
DR   PDB; 4H5C; X-ray; 2.02 A; F=67-419.
DR   PDB; 4H5D; X-ray; 2.02 A; F=67-419.
DR   PDB; 4H5E; X-ray; 2.04 A; F=67-419.
DR   PDB; 4JVJ; X-ray; 2.80 A; F=67-419.
DR   PDB; 4KFA; X-ray; 1.98 A; A=67-419.
DR   PDB; 4KPD; X-ray; 1.96 A; A=67-419.
DR   PDB; 4KPJ; X-ray; 1.95 A; A=67-419.
DR   PDB; 4KQ5; X-ray; 2.40 A; A=67-419.
DR   PDB; 4KQS; X-ray; 1.97 A; A=67-419.
DR   PDB; 4KQU; X-ray; 2.07 A; A=67-419.
DR   PDB; 4L2X; X-ray; 2.55 A; F=67-419.
DR   PDB; 4LFV; X-ray; 2.00 A; F=67-419.
DR   PDB; 4LPG; X-ray; 2.35 A; F=67-419.
DR   PDB; 4LPH; X-ray; 2.30 A; F=67-419.
DR   PDB; 4N1Z; X-ray; 2.35 A; F=72-419.
DR   PDB; 4N9U; X-ray; 2.11 A; A=67-419.
DR   PDB; 4NFI; X-ray; 1.85 A; F=67-419.
DR   PDB; 4NFJ; X-ray; 2.05 A; F=67-419.
DR   PDB; 4NFK; X-ray; 1.85 A; F=67-419.
DR   PDB; 4NG6; X-ray; 2.35 A; A=67-419.
DR   PDB; 4NKE; X-ray; 1.46 A; A=67-419.
DR   PDB; 4NKF; X-ray; 2.00 A; A=67-419.
DR   PDB; 4NUA; X-ray; 1.43 A; A=67-419.
DR   PDB; 4OGU; X-ray; 2.10 A; A=67-419.
DR   PDB; 4P0V; X-ray; 2.40 A; A=73-419.
DR   PDB; 4P0W; X-ray; 2.41 A; A=72-419.
DR   PDB; 4P0X; X-ray; 2.50 A; A=72-419.
DR   PDB; 4PVX; X-ray; 2.18 A; F=67-419.
DR   PDB; 4PVY; X-ray; 2.05 A; F=67-419.
DR   PDB; 4Q23; X-ray; 1.98 A; A=67-419.
DR   PDB; 4QPF; X-ray; 1.59 A; A=67-419.
DR   PDB; 4QXS; X-ray; 1.90 A; F=67-419.
DR   PDB; 4RXA; X-ray; 2.20 A; A=72-419.
DR   PDB; 4XQR; X-ray; 2.15 A; F=67-419.
DR   PDB; 4XQS; X-ray; 2.30 A; F=67-419.
DR   PDB; 4XQT; X-ray; 2.10 A; F=67-419.
DR   PDB; 5CG5; Other; 1.40 A; A=74-419.
DR   PDB; 5CG6; Other; 1.70 A; A=74-419.
DR   PDB; 5DGM; X-ray; 2.86 A; F=72-419.
DR   PDB; 5DGN; X-ray; 2.08 A; F=72-419.
DR   PDB; 5DGS; X-ray; 2.62 A; F=72-419.
DR   PDB; 5DIQ; X-ray; 2.10 A; F=72-419.
DR   PDB; 5DJP; X-ray; 2.40 A; F=72-419.
DR   PDB; 5DJR; X-ray; 2.40 A; F=72-419.
DR   PDB; 5DJV; X-ray; 2.30 A; F=72-419.
DR   PDB; 5JA0; X-ray; 1.90 A; F=67-419.
DR   PDB; 5JUZ; X-ray; 2.40 A; F=67-419.
DR   PDB; 5JV0; X-ray; 2.40 A; F=67-419.
DR   PDB; 5JV1; X-ray; 2.30 A; F=67-419.
DR   PDB; 5JV2; X-ray; 2.30 A; F=67-419.
DR   PDB; 5KSX; X-ray; 2.65 A; F=67-419.
DR   PDBsum; 1YQ7; -.
DR   PDBsum; 1YV5; -.
DR   PDBsum; 1ZW5; -.
DR   PDBsum; 2F7M; -.
DR   PDBsum; 2F89; -.
DR   PDBsum; 2F8C; -.
DR   PDBsum; 2F8Z; -.
DR   PDBsum; 2F92; -.
DR   PDBsum; 2F94; -.
DR   PDBsum; 2F9K; -.
DR   PDBsum; 2OPM; -.
DR   PDBsum; 2OPN; -.
DR   PDBsum; 2QIS; -.
DR   PDBsum; 2RAH; -.
DR   PDBsum; 2VF6; -.
DR   PDBsum; 3B7L; -.
DR   PDBsum; 3CP6; -.
DR   PDBsum; 3N1V; -.
DR   PDBsum; 3N1W; -.
DR   PDBsum; 3N3L; -.
DR   PDBsum; 3N45; -.
DR   PDBsum; 3N46; -.
DR   PDBsum; 3N49; -.
DR   PDBsum; 3N5H; -.
DR   PDBsum; 3N5J; -.
DR   PDBsum; 3N6K; -.
DR   PDBsum; 3RYE; -.
DR   PDBsum; 3S4J; -.
DR   PDBsum; 4DEM; -.
DR   PDBsum; 4GA3; -.
DR   PDBsum; 4H5C; -.
DR   PDBsum; 4H5D; -.
DR   PDBsum; 4H5E; -.
DR   PDBsum; 4JVJ; -.
DR   PDBsum; 4KFA; -.
DR   PDBsum; 4KPD; -.
DR   PDBsum; 4KPJ; -.
DR   PDBsum; 4KQ5; -.
DR   PDBsum; 4KQS; -.
DR   PDBsum; 4KQU; -.
DR   PDBsum; 4L2X; -.
DR   PDBsum; 4LFV; -.
DR   PDBsum; 4LPG; -.
DR   PDBsum; 4LPH; -.
DR   PDBsum; 4N1Z; -.
DR   PDBsum; 4N9U; -.
DR   PDBsum; 4NFI; -.
DR   PDBsum; 4NFJ; -.
DR   PDBsum; 4NFK; -.
DR   PDBsum; 4NG6; -.
DR   PDBsum; 4NKE; -.
DR   PDBsum; 4NKF; -.
DR   PDBsum; 4NUA; -.
DR   PDBsum; 4OGU; -.
DR   PDBsum; 4P0V; -.
DR   PDBsum; 4P0W; -.
DR   PDBsum; 4P0X; -.
DR   PDBsum; 4PVX; -.
DR   PDBsum; 4PVY; -.
DR   PDBsum; 4Q23; -.
DR   PDBsum; 4QPF; -.
DR   PDBsum; 4QXS; -.
DR   PDBsum; 4RXA; -.
DR   PDBsum; 4XQR; -.
DR   PDBsum; 4XQS; -.
DR   PDBsum; 4XQT; -.
DR   PDBsum; 5CG5; -.
DR   PDBsum; 5CG6; -.
DR   PDBsum; 5DGM; -.
DR   PDBsum; 5DGN; -.
DR   PDBsum; 5DGS; -.
DR   PDBsum; 5DIQ; -.
DR   PDBsum; 5DJP; -.
DR   PDBsum; 5DJR; -.
DR   PDBsum; 5DJV; -.
DR   PDBsum; 5JA0; -.
DR   PDBsum; 5JUZ; -.
DR   PDBsum; 5JV0; -.
DR   PDBsum; 5JV1; -.
DR   PDBsum; 5JV2; -.
DR   PDBsum; 5KSX; -.
DR   ProteinModelPortal; P14324; -.
DR   SMR; P14324; -.
DR   BioGrid; 108517; 49.
DR   DIP; DIP-50059N; -.
DR   IntAct; P14324; 6.
DR   MINT; MINT-2858951; -.
DR   STRING; 9606.ENSP00000349078; -.
DR   BindingDB; P14324; -.
DR   ChEMBL; CHEMBL1782; -.
DR   DrugBank; DB00630; Alendronic acid.
DR   DrugBank; DB01785; Dimethylallyl Diphosphate.
DR   DrugBank; DB07780; FARNESYL DIPHOSPHATE.
DR   DrugBank; DB02552; Geranyl Diphosphate.
DR   DrugBank; DB07841; GERANYLGERANYL DIPHOSPHATE.
DR   DrugBank; DB00710; Ibandronate.
DR   DrugBank; DB04714; ISOPENTENYL PYROPHOSPHATE.
DR   DrugBank; DB02508; Isopentyl Pyrophosphate.
DR   DrugBank; DB00282; Pamidronate.
DR   DrugBank; DB00884; Risedronate.
DR   DrugBank; DB00399; Zoledronic acid.
DR   GuidetoPHARMACOLOGY; 644; -.
DR   SwissLipids; SLP:000001248; -.
DR   SwissLipids; SLP:000001252; -. [P14324-2]
DR   iPTMnet; P14324; -.
DR   PhosphoSitePlus; P14324; -.
DR   SwissPalm; P14324; -.
DR   BioMuta; FDPS; -.
DR   DMDM; 215274250; -.
DR   EPD; P14324; -.
DR   MaxQB; P14324; -.
DR   PaxDb; P14324; -.
DR   PeptideAtlas; P14324; -.
DR   PRIDE; P14324; -.
DR   TopDownProteomics; P14324-1; -. [P14324-1]
DR   DNASU; 2224; -.
DR   Ensembl; ENST00000356657; ENSP00000349078; ENSG00000160752. [P14324-1]
DR   Ensembl; ENST00000368356; ENSP00000357340; ENSG00000160752. [P14324-1]
DR   Ensembl; ENST00000447866; ENSP00000391755; ENSG00000160752. [P14324-2]
DR   Ensembl; ENST00000467076; ENSP00000480142; ENSG00000160752. [P14324-2]
DR   Ensembl; ENST00000612683; ENSP00000478235; ENSG00000160752. [P14324-2]
DR   GeneID; 2224; -.
DR   KEGG; hsa:2224; -.
DR   UCSC; uc001fkc.3; human. [P14324-1]
DR   CTD; 2224; -.
DR   DisGeNET; 2224; -.
DR   GeneCards; FDPS; -.
DR   H-InvDB; HIX0025342; -.
DR   HGNC; HGNC:3631; FDPS.
DR   HPA; HPA028200; -.
DR   MalaCards; FDPS; -.
DR   MIM; 134629; gene.
DR   MIM; 616631; phenotype.
DR   neXtProt; NX_P14324; -.
DR   OpenTargets; ENSG00000160752; -.
DR   PharmGKB; PA28075; -.
DR   eggNOG; KOG0711; Eukaryota.
DR   eggNOG; COG0142; LUCA.
DR   GeneTree; ENSGT00870000136449; -.
DR   HOGENOM; HOG000160912; -.
DR   HOVERGEN; HBG005741; -.
DR   InParanoid; P14324; -.
DR   KO; K00787; -.
DR   OMA; RMAGVTD; -.
DR   OrthoDB; EOG091G0BPT; -.
DR   PhylomeDB; P14324; -.
DR   TreeFam; TF300897; -.
DR   BioCyc; MetaCyc:ENSG00000160752-MONOMER; -.
DR   BRENDA; 2.5.1.10; 2681.
DR   Reactome; R-HSA-191273; Cholesterol biosynthesis.
DR   Reactome; R-HSA-2426168; Activation of gene expression by SREBF (SREBP).
DR   SABIO-RK; P14324; -.
DR   UniPathway; UPA00259; UER00368.
DR   UniPathway; UPA00260; UER00369.
DR   ChiTaRS; FDPS; human.
DR   EvolutionaryTrace; P14324; -.
DR   GenomeRNAi; 2224; -.
DR   PRO; PR:P14324; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000160752; -.
DR   CleanEx; HS_FDPS; -.
DR   ExpressionAtlas; P14324; baseline and differential.
DR   Genevisible; P14324; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0004161; F:dimethylallyltranstransferase activity; IBA:GO_Central.
DR   GO; GO:0004337; F:geranyltranstransferase activity; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0006695; P:cholesterol biosynthetic process; TAS:Reactome.
DR   GO; GO:0045337; P:farnesyl diphosphate biosynthetic process; IBA:GO_Central.
DR   GO; GO:0033384; P:geranyl diphosphate biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   Gene3D; 1.10.600.10; -; 1.
DR   InterPro; IPR008949; Isoprenoid_synthase_dom.
DR   InterPro; IPR000092; Polyprenyl_synt.
DR   InterPro; IPR033749; Polyprenyl_synt_CS.
DR   Pfam; PF00348; polyprenyl_synt; 1.
DR   SUPFAM; SSF48576; SSF48576; 1.
DR   PROSITE; PS00723; POLYPRENYL_SYNTHASE_1; 1.
DR   PROSITE; PS00444; POLYPRENYL_SYNTHASE_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing;
KW   Cholesterol biosynthesis; Cholesterol metabolism; Complete proteome;
KW   Cytoplasm; Disease mutation; Host-virus interaction;
KW   Isoprene biosynthesis; Lipid biosynthesis; Lipid metabolism;
KW   Magnesium; Metal-binding; Polymorphism; Reference proteome;
KW   Steroid biosynthesis; Steroid metabolism; Sterol biosynthesis;
KW   Sterol metabolism; Transferase.
FT   CHAIN         1    419       Farnesyl pyrophosphate synthase.
FT                                /FTId=PRO_0000123944.
FT   METAL       169    169       Magnesium 1.
FT   METAL       169    169       Magnesium 2.
FT   METAL       173    173       Magnesium 1.
FT   METAL       173    173       Magnesium 2.
FT   METAL       309    309       Magnesium 3.
FT   BINDING     123    123       Isopentenyl diphosphate.
FT   BINDING     126    126       Isopentenyl diphosphate.
FT   BINDING     162    162       Isopentenyl diphosphate.
FT   BINDING     178    178       Dimethylallyl diphosphate.
FT   BINDING     179    179       Isopentenyl diphosphate.
FT   BINDING     266    266       Dimethylallyl diphosphate.
FT   BINDING     267    267       Dimethylallyl diphosphate.
FT   BINDING     306    306       Dimethylallyl diphosphate.
FT   BINDING     323    323       Dimethylallyl diphosphate.
FT   BINDING     332    332       Dimethylallyl diphosphate. {ECO:0000250}.
FT   SITE        164    164       Important for determining product chain
FT                                length. {ECO:0000250}.
FT   SITE        165    165       Important for determining product chain
FT                                length. {ECO:0000250}.
FT   MOD_RES     123    123       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     353    353       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   VAR_SEQ       1     66       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:1968462,
FT                                ECO:0000303|Ref.7}.
FT                                /FTId=VSP_046958.
FT   VARIANT     179    179       R -> Q (in POROK9; dbSNP:rs863225241).
FT                                {ECO:0000269|PubMed:26202976}.
FT                                /FTId=VAR_075062.
FT   VARIANT     364    364       V -> A (in dbSNP:rs41314549).
FT                                /FTId=VAR_061274.
FT   VARIANT     391    391       I -> V (in dbSNP:rs17456).
FT                                /FTId=VAR_049644.
FT   CONFLICT    141    141       R -> K (in Ref. 7; BQ062616).
FT                                {ECO:0000305}.
FT   CONFLICT    182    182       I -> T (in Ref. 1; AAA52423).
FT                                {ECO:0000305}.
FT   CONFLICT    284    284       G -> R (in Ref. 7; BQ062616).
FT                                {ECO:0000305}.
FT   HELIX        76     85       {ECO:0000244|PDB:4NUA}.
FT   HELIX        87     94       {ECO:0000244|PDB:4NUA}.
FT   HELIX        97    100       {ECO:0000244|PDB:4DEM}.
FT   HELIX       102    104       {ECO:0000244|PDB:4NUA}.
FT   HELIX       105    118       {ECO:0000244|PDB:4NUA}.
FT   STRAND      119    122       {ECO:0000244|PDB:4NUA}.
FT   HELIX       125    137       {ECO:0000244|PDB:4NUA}.
FT   HELIX       140    142       {ECO:0000244|PDB:4NUA}.
FT   HELIX       145    172       {ECO:0000244|PDB:4NUA}.
FT   STRAND      176    178       {ECO:0000244|PDB:4QXS}.
FT   HELIX       184    186       {ECO:0000244|PDB:4NUA}.
FT   TURN        188    190       {ECO:0000244|PDB:4NUA}.
FT   HELIX       191    193       {ECO:0000244|PDB:4NUA}.
FT   HELIX       194    213       {ECO:0000244|PDB:4NUA}.
FT   HELIX       219    243       {ECO:0000244|PDB:4NUA}.
FT   STRAND      246    248       {ECO:0000244|PDB:4JVJ}.
FT   HELIX       251    253       {ECO:0000244|PDB:4NUA}.
FT   HELIX       256    266       {ECO:0000244|PDB:4NUA}.
FT   HELIX       268    271       {ECO:0000244|PDB:4NUA}.
FT   HELIX       273    282       {ECO:0000244|PDB:4NUA}.
FT   HELIX       288    315       {ECO:0000244|PDB:4NUA}.
FT   HELIX       318    321       {ECO:0000244|PDB:4NUA}.
FT   TURN        327    331       {ECO:0000244|PDB:4NUA}.
FT   HELIX       335    343       {ECO:0000244|PDB:4NUA}.
FT   HELIX       346    355       {ECO:0000244|PDB:4NUA}.
FT   HELIX       361    373       {ECO:0000244|PDB:4NUA}.
FT   HELIX       376    398       {ECO:0000244|PDB:4NUA}.
FT   HELIX       404    414       {ECO:0000244|PDB:4NUA}.
SQ   SEQUENCE   419 AA;  48275 MW;  52934B80A808FB67 CRC64;
     MPLSRWLRSV GVFLLPAPYW APRERWLGSL RRPSLVHGYP VLAWHSARCW CQAWTEEPRA
     LCSSLRMNGD QNSDVYAQEK QDFVQHFSQI VRVLTEDEMG HPEIGDAIAR LKEVLEYNAI
     GGKYNRGLTV VVAFRELVEP RKQDADSLQR AWTVGWCVEL LQAFFLVADD IMDSSLTRRG
     QICWYQKPGV GLDAINDANL LEACIYRLLK LYCREQPYYL NLIELFLQSS YQTEIGQTLD
     LLTAPQGNVD LVRFTEKRYK SIVKYKTAFY SFYLPIAAAM YMAGIDGEKE HANAKKILLE
     MGEFFQIQDD YLDLFGDPSV TGKIGTDIQD NKCSWLVVQC LQRATPEQYQ ILKENYGQKE
     AEKVARVKAL YEELDLPAVF LQYEEDSYSH IMALIEQYAA PLPPAVFLGL ARKIYKRRK
//
